These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


112 related items for PubMed ID: 6700386

  • 1. [Metronidazole: basic experimental results and clinical prospects].
    Pelevina II, Voronina SS, Karakulov RK, Potapov SL, Dronova LM.
    Med Radiol (Mosk); 1984 Feb; 29(2):10-20. PubMed ID: 6700386
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Selective radiosensitization of the hypoxic cells of mouse tumors with the nitroimidazoles metronidazole and Ro 7-0582.
    Brown JM.
    Radiat Res; 1975 Dec; 64(3):633-47. PubMed ID: 1197663
    [No Abstract] [Full Text] [Related]

  • 6. [Effect of 4-nitroimidazole (iso-metronidazole) on the radiation-induced growth retardation and therapeutic quotient of transplanted tumors].
    Magdon E.
    Radiobiol Radiother (Berl); 1985 Dec; 26(3):351-8. PubMed ID: 4059521
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of hypoxic cell sensitizer metronidazole on the radiation reaction of clonogenic cells from solid tumors].
    Gulverdashvili NA, Afanas'ev GG, Pelevina II.
    Radiobiologiia; 1987 Dec; 27(5):636-40. PubMed ID: 3671679
    [Abstract] [Full Text] [Related]

  • 8. [Comparison of the radiosensitizing action of metronidazole administered orally and locally].
    Volchkov VA, Rudenko IIa, Zharinov GM, Khanson KP, Kholin VV.
    Radiobiologiia; 1988 Dec; 28(1):128-30. PubMed ID: 3344324
    [Abstract] [Full Text] [Related]

  • 9. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M, Malaise EP.
    Pathol Biol (Paris); 1980 Jan; 28(1):29-42. PubMed ID: 6153787
    [Abstract] [Full Text] [Related]

  • 10. Chemosensitization and radiosensitization of human lung and colon cancers by antimitotic agent, ABT-751, in athymic murine xenograft models of subcutaneous tumor growth.
    Jorgensen TJ, Tian H, Joseph IB, Menon K, Frost D.
    Cancer Chemother Pharmacol; 2007 May; 59(6):725-32. PubMed ID: 16967299
    [Abstract] [Full Text] [Related]

  • 11. The role of radiosensitizing drugs in the management of cancer.
    Adams GE.
    Invest Cell Pathol; 1979 May; 2(4):303-8. PubMed ID: 396284
    [Abstract] [Full Text] [Related]

  • 12. [Comparative studies on the radiosensitizing action of 4-nitroimidazole and metronidazole (author's transl)].
    Magdon E, Schröder E.
    Arch Geschwulstforsch; 1981 May; 51(3):225-30. PubMed ID: 7271431
    [Abstract] [Full Text] [Related]

  • 13. [Recent data on biological and clinical properties of radiosensitizers (author's transl)].
    Guichard M, Malaise EP.
    Sem Hop; 1981 May; 56(21-24):1094-107. PubMed ID: 6156491
    [Abstract] [Full Text] [Related]

  • 14. [Increasing the effectiveness of tumor radiotherapy with metronidazole].
    Voronina SS, Pelevina II.
    Med Radiol (Mosk); 1977 Jun; 22(6):37-43. PubMed ID: 881955
    [No Abstract] [Full Text] [Related]

  • 15. Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.
    Crokart N, Radermacher K, Jordan BF, Baudelet C, Cron GO, Grégoire V, Beghein N, Bouzin C, Feron O, Gallez B.
    Cancer Res; 2005 Sep 01; 65(17):7911-6. PubMed ID: 16140962
    [Abstract] [Full Text] [Related]

  • 16. The effect of N-methylformamide on radiocurability of murine tumors.
    Iwakawa M, Milas L.
    Radiat Res; 1988 Jan 01; 113(1):199-203. PubMed ID: 3340723
    [Abstract] [Full Text] [Related]

  • 17. [Concept of therapeutic ratio by combination of radiotherapy and chemotherapy].
    Tanaka Y.
    Gan No Rinsho; 1983 Oct 01; 29(13):1579-83. PubMed ID: 6668667
    [Abstract] [Full Text] [Related]

  • 18. Lack of differential radiosensitization of hypoxic cells in a mouse tumor at low radiation doses per fraction by cisplatin.
    Sun JR, Brown JM.
    Radiat Res; 1993 Feb 01; 133(2):252-6. PubMed ID: 8438067
    [Abstract] [Full Text] [Related]

  • 19. Effect of the hypoxic cell sensitizer isometronidazole on local control of two human squamous cell carcinomas after fractionated irradiation.
    Schreiber A, Krause M, Zips D, Dörfler A, Richter K, Vettermann S, Petersen C, Beuthien-Baumann B, Thümmler D, Baumann M.
    Strahlenther Onkol; 2004 Jun 01; 180(6):375-82. PubMed ID: 15175873
    [Abstract] [Full Text] [Related]

  • 20. [Possibility of lowering the dose of metronidazole during the irradiation of tumors using subsequent artificial hyperglycemia].
    Vinskaia NP, Voloshina EA, Kozin SV.
    Med Radiol (Mosk); 1989 Oct 01; 34(10):61-5. PubMed ID: 2811633
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.